AI-powered Alex DTx Platform works with pharmaceutical companies and helps prescribe digital therapies.
Alex Therapeutics has raised €3.5M across 1 funding round from 3 investors, most recently a round in Apr 2022. Based in Stockholm, Sweden; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-06 | Other |
| €3.5M |
| Bonit Capital,Hadean Ventures,Scale Capital |
| View deal → |
